SCHEMBL31701082

SCHEMBL31701082

CC(C)(C)OC(=O)N1CCn2c(CCl)nnc2C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.47
NR1H2 P55055 2/20 0.43
P2RX7 Q99572 3/20 0.40
POLB P06746 1/20 0.38
HTT P42858 1/20 0.38
ATM Q13315 1/20 0.38
CYP8B1 Q9UNU6 1/20 0.37
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
ESR2 Q92731 1/20 0.37
USP2 O75604 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
TTK P33981 1/20 0.37
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
MAPT P10636 1/20 0.36
MAPK1 P28482 1/20 0.36
DDB1 Q16531 1/20 0.36
CRBN Q96SW2 1/20 0.36
PDK2 Q15119 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26126866 0.88 NR1H2 (0.44) FAAHNR1H2P2RX7HTTATM
SCHEMBL26122137 0.87 NR1H2 (0.43) NR1H2P2RX7HTTATMCYP8B1
SCHEMBL26128727 0.86 NR1H2 (0.45) NR1H2P2RX7HTTATMCYP8B1
SCHEMBL4399130 0.83 NR1H2 (0.40) NR1H2P2RX7HTTATMCYP8B1
SCHEMBL10095021 0.81 NR1H2 (0.47) NR1H2P2RX7POLBHTTATM
SCHEMBL15580338 0.80 NR1H2 (0.46) NR1H2POLBHTTATMCYP8B1
SCHEMBL1497486 0.80 P2RX7 (0.49) NR1H2P2RX7HTTATMCYP8B1
SCHEMBL22952373 0.80 P2RX7 (0.48) NR1H2P2RX7POLBHTTATM
SCHEMBL573286 0.78 NR1H2 (0.45) NR1H2P2RX7HTTATMCYP8B1
SCHEMBL20775252 0.78 NR1H2 (0.45) NR1H2POLBHTTATMCYP8B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260014147-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2026-01-15 US disclosed
US-20250325677-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-23 US disclosed
US-20250320205-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed
US-20250320206-A1 STAT6 DEGRADERS GILEAD SCIENCES INC (US) 2025-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250325677-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 FAAH 1632/4885NR1H2 1224/4885P2RX7 3396/4885
US-20250320205-A1 STAT6 DEGRADERS STAT6, STAT1, STAT5B FAAH 1845/4885NR1H2 1188/4885P2RX7 3300/4885
US-20260014147-A1 STAT6 DEGRADERS STAT6, NCOR1, CBR1 FAAH 956/4885NR1H2 137/4885P2RX7 1477/4885
US-20250320206-A1 STAT6 DEGRADERS STAT6, STAT5B, STAT1 FAAH 1632/4885NR1H2 1224/4885P2RX7 3396/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.